Two VMAT2 radioligands [11C]DTBZand [18F]FP-DTBZ have been used to assess the degree ofnigrostriatal deficit in Parkinson’s disease (PD) using positronemission tomography (PET). The gene discussed is SLC18A2; the disease is Parkinson disease.